Spots Global Cancer Trial Database for Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Official Title: Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer
Study ID: NCT02334579
Interventions
Study Description
Brief Summary: The purpose of this study is to find out the effects (good and bad) of highly focused radiation on you and your prostate cancer. The purpose of this evaluation is to see if this treatment causes fewer side effects that other standard treatment approaches, and to evaluate the effect of this treatment on your prostate tumor and your quality of life over time.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Swedish Medical Center Radiosurgery Center, Seattle, Washington, United States
Contact Details
Name: Robert Meier, MD
Affiliation: Swedish Medical Center Radiosurgery Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
